Sanofi India Limited (BOM:500674)
3,560.00
+37.75 (1.07%)
At close: Apr 16, 2026
Sanofi India Balance Sheet
Financials in millions INR. Fiscal year is January - December.
Millions INR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,629 | 2,838 | 3,945 | 10,049 | 15,380 |
Cash & Short-Term Investments | 2,629 | 2,838 | 3,945 | 10,049 | 15,380 |
Cash Growth | -7.36% | -28.06% | -60.74% | -34.66% | 28.44% |
Accounts Receivable | 1,767 | 2,300 | 1,317 | 1,291 | 1,429 |
Other Receivables | 30 | 455 | 74 | 61 | 81 |
Receivables | 1,806 | 2,765 | 1,410 | 1,372 | 1,537 |
Inventory | 3,116 | 4,998 | 6,638 | 4,080 | 3,924 |
Prepaid Expenses | 66 | 115 | 71 | 81 | 51 |
Other Current Assets | 389 | 552 | 416 | 521 | 487 |
Total Current Assets | 8,006 | 11,268 | 12,480 | 16,103 | 21,379 |
Property, Plant & Equipment | 3,150 | 3,293 | 3,233 | 3,240 | 3,417 |
Other Intangible Assets | 7 | 13 | 75 | 51 | 52 |
Long-Term Deferred Tax Assets | 44 | 1 | - | - | - |
Other Long-Term Assets | 1,341 | 1,543 | 1,360 | 1,323 | 1,312 |
Total Assets | 12,548 | 16,118 | 17,148 | 20,717 | 30,610 |
Accounts Payable | 1,940 | 4,063 | 2,915 | 3,564 | 3,767 |
Accrued Expenses | 1,042 | 1,120 | 1,351 | 1,596 | 1,513 |
Current Portion of Leases | 41 | 53 | 51 | 87 | 70 |
Current Income Taxes Payable | 957 | 959 | 1,015 | 900 | 1,067 |
Current Unearned Revenue | - | - | - | 47 | 43 |
Other Current Liabilities | 934 | 1,170 | 1,181 | 1,212 | 1,036 |
Total Current Liabilities | 4,914 | 7,365 | 6,513 | 7,406 | 7,496 |
Long-Term Leases | 137 | 140 | 139 | 149 | 176 |
Pension & Post-Retirement Benefits | 5 | 7 | 307 | 355 | 619 |
Long-Term Deferred Tax Liabilities | - | - | 37 | 49 | 63 |
Total Liabilities | 5,056 | 7,512 | 6,996 | 7,959 | 8,354 |
Common Stock | 230 | 230 | 230 | 230 | 230 |
Additional Paid-In Capital | 20 | 20 | 20 | 20 | 20 |
Retained Earnings | 6,523 | 7,661 | 9,219 | 11,886 | 21,405 |
Comprehensive Income & Other | 719 | 695 | 683 | 622 | 601 |
Shareholders' Equity | 7,492 | 8,606 | 10,152 | 12,758 | 22,256 |
Total Liabilities & Equity | 12,548 | 16,118 | 17,148 | 20,717 | 30,610 |
Total Debt | 178 | 193 | 190 | 236 | 246 |
Net Cash (Debt) | 2,451 | 2,645 | 3,755 | 9,813 | 15,134 |
Net Cash Growth | -7.33% | -29.56% | -61.73% | -35.16% | 28.82% |
Net Cash Per Share | 106.42 | 114.85 | 163.04 | 426.08 | 657.13 |
Filing Date Shares Outstanding | 23.03 | 23.03 | 23.03 | 23.03 | 23.03 |
Total Common Shares Outstanding | 23.03 | 23.03 | 23.03 | 23.03 | 23.03 |
Working Capital | 3,092 | 3,903 | 5,967 | 8,697 | 13,883 |
Book Value Per Share | 325.31 | 373.68 | 440.80 | 553.96 | 966.37 |
Tangible Book Value | 7,485 | 8,593 | 10,077 | 12,707 | 22,204 |
Tangible Book Value Per Share | 325.00 | 373.11 | 437.55 | 551.74 | 964.11 |
Buildings | 2,644 | 2,544 | 2,362 | 2,192 | 2,301 |
Machinery | 2,503 | 2,427 | 2,370 | 2,313 | 2,338 |
Construction In Progress | 116 | 181 | 133 | 188 | 89 |
Leasehold Improvements | - | - | - | 23 | 28 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.